FOXD3 Is Functionally Linked to NF-κB Signaling in KRAS G12C-Mutant NSCLC Cells
Cells · 2026
DOI: 10.3390/cells15171564 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Pengzhen Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, NF-kappa B, Lung Neoplasms, Signal Transduction. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Provincial Natural Science Foundation, the fund of Yangtze Delta Region Institute of Tsinghua University, Zhejiang, the Innovation Guidance Special Program for New-type Research and Development Institutions in Jiaxing.
Abstract (Originalsprache)
KRAS G12C mutation is a clinically relevant driver in non-small cell lung cancer (NSCLC), yet the signaling networks that modulate malignant behavior in this context remain incompletely defined. In this study, we examined the functional role of FOXD3 and its relationship with NF-κB signaling in KRAS G12C-mutant NSCLC models. Stable FOXD3 overexpression was established in SW1573 and LU65 cells. FOXD3 reduced cell viability, migration, and invasion while increasing caspase 3/7 activity in both cell lines. Transcriptomic profiling in LU65 cells followed by Hallmark enrichment analysis identified TNFα signaling via NF-κB as a prominently altered pathway associated with FOXD3 overexpression. Consistently, NF-κB dual-luciferase assays showed reduced basal NF-κB transcriptional activity in FOXD3-overexpressing cells. TNFα stimulation partially reversed the inhibitory effects of FOXD3 on proliferation, migration, and invasion and attenuated FOXD3-induced apoptosis. In addition, stable FOXD3 overexpression suppressed xenograft growth in vivo. Collectively, these findings support a functional association between FOXD3 overexpression and reduced NF-κB-related transcriptional activity in KRAS G12C-mutant NSCLC models, although the present data do not establish direct causal mediation by NF-κB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China.
- Zhejiang Key Laboratory of Multiomics and Molecular Enzymology, Yangtze Delta Region Institute of Tsinghua University, Zhejiang, Jiaxing 314006, China.
- Women's Hospital, School of Medicine, Zhejiang University, Hangzhou 310018, China.
- Qingdao Academy, Qingdao 266111, China.
ORCID-Profile: Qing Sheng, Wenfei Xu
Förderung
- Zhejiang Provincial Natural Science Foundation
- the fund of Yangtze Delta Region Institute of Tsinghua University, Zhejiang
- the Innovation Guidance Special Program for New-type Research and Development Institutions in Jiaxing
- the Collaborative Project with China Resources Research Institute of Science & Technology
- the Key Research and Development Program of Shihezi City
- Zhejiang Provincial Natural Science Foundation of China
Zitieren
APA
Xu, P., Peng, J., Guo, C., Liu, Z., Cao, Y., Sheng, Q., Xu, W., & Li, X. (2026). FOXD3 Is Functionally Linked to NF-κB Signaling in KRAS G12C-Mutant NSCLC Cells. Cells. https://doi.org/10.3390/cells15171564
Vancouver
Xu P, Peng J, Guo C, Liu Z, Cao Y, Sheng Q, et al. FOXD3 Is Functionally Linked to NF-κB Signaling in KRAS G12C-Mutant NSCLC Cells. Cells. 2026. doi:10.3390/cells15171564
BibTeX
@article{Xu2026,
author = {Xu, Pengzhen and Peng, Jie and Guo, Chao and Liu, Zhu and Cao, Yufeng and Sheng, Qing and Xu, Wenfei and Li, Xuhui},
title = {FOXD3 Is Functionally Linked to NF-κB Signaling in KRAS G12C-Mutant NSCLC Cells},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15171564}
}
EUVIMED